AltraOne Insights logo
AltraOne Insights
Insights
Open AltraOne
AltraOne Insights
© AltraOne Insights 2026. All rights reserved.
< All insights

Momentum Turn: JIOFIN, SBIN, BIOCON Go Bullish

JIOFIN, SBIN, and BIOCON recently surged to bullish momentum, with Altra Scores hitting 64.2, 86.0, and 83.0 respectively, signalling cross-sector

July 11, 2026NSE
  • Visit the stock pages: JIOFIN, SBIN, BIOCON
  • Sector Nifty Financial Services Sector , which ranks #3 for Relative Strength (Altra Sector score of 54.0 with bullish regime.)

On July 10, 2026, the NSE market displayed an improving texture, with its Altra Market score registering 60.7. This score, which provides a broader read on overall market breadth by measuring the percentage of stocks positioned above key Exponential Moving Averages (EMAs), suggests a more positive environment. Market breadth reflected this, with 56.0% of stocks trading above their 20-day and 50-day EMAs, and 54.0% above their 200-day EMA. The advance/decline ratio of 42/8 further underscored this positive shift, aligning with an overall 15-day score trend of +3.5. This improving market sentiment has coincided with significant bullish momentum shifts in key stocks across diverse sectors.

The Altra Score, a 0-100 momentum gauge, provides a detailed read on a stock's trend, derived from its EMA alignment and Relative Strength Index (RSI) across daily, weekly, and monthly timeframes. A higher score signifies stronger bullish momentum. Simultaneously, the Altra Sector score assesses sector-wide momentum and its relative strength ranking compared to other sectors.

Jio Financial Services Ltd. (JIOFIN)

Jio Financial Services witnessed a notable shift in its momentum, with its Altra Score jumping from 23.2 to 64.2 on July 10, 2026, moving from a Bearish to a Bullish regime. This change positions JIOFIN firmly in a positive momentum phase. Despite a bearish Weekly EMA Crossover observed earlier in the year on January 9, 2026, the stock's current EMA placement indicates it is now trading above its key EMAs, signifying underlying strength. Its daily RSI stands at 54.44, with weekly and monthly RSIs at 43.89 and 44.77 respectively, suggesting a constructive short-term trend. The Nifty Financial Services Sector, to which JIOFIN belongs, holds an Altra Sector score of 54.0, ranking 3rd overall and displaying a bullish outlook. The sector itself is characterized as a 'Confirmed leader, cooling off', with a 4-week Relative Strength (RS) trend of +1.02 and an RS RSI of 63.3.

State Bank of India (SBIN)

State Bank of India demonstrated a robust surge in momentum, with its Altra Score climbing significantly from 51.2 to 86.0 on July 10, 2026, elevating its status from Neutral to Strong Bullish. This powerful move is supported by a bullish Weekly EMA Crossover that occurred more recently on June 22, 2026. SBIN's EMA placement shows it is comfortably above its key EMAs, and it exhibits 'top-down alignment', indicating consistent bullish momentum across multiple timeframes. The daily RSI for SBIN is 54.63, with weekly at 52.57 and monthly at 59.32, all suggesting a healthy underlying trend. The Nifty Bank Sector, where SBIN is a prominent player, carries an Altra Sector score of 59.0, ranking 2nd and also reflecting a bullish phase. Similar to the financial services sector, Nifty Bank is identified as a 'Confirmed leader, cooling off', with an RS 4-week trend of -0.73 and an RS RSI of 61.9.

Biocon Ltd. (BIOCON)

Biocon also experienced a substantial leap into a Strong Bullish momentum regime, as its Altra Score surged from 43.4 to 83.0 on July 10, 2026. This strong momentum is further validated by a bullish Weekly EMA Crossover recorded on May 15, 2026. BIOCON's EMA placement is above its key EMAs, and it too shows 'top-down alignment', reinforcing the strength of its multi-timeframe trend. Its daily RSI is 52.98, while weekly and monthly RSIs are robust at 59.41 and 59.29 respectively. Notably, Biocon is part of the Nifty Pharma Sector, which currently stands as the #1 ranked sector with an impressive Altra Sector score of 92.0, firmly in a bullish phase. The Nifty Pharma sector is described as a 'Confirmed leader, accelerating', with a strong RS 4-week trend of +2.92 and a high RS RSI of 71.4, signaling sustained upward momentum.

What is the Altra Score? The Altra Score is AltraOne's proprietary momentum score for individual stocks, ranging from 0 to 100. It measures EMA structure and RSI momentum across multiple timeframes. A score above 60 is Bullish, below 40 is Bearish, and 40–60 is Neutral. The score is updated every trading day after market close based on end-of-day data.

Explore the full Signal History on AltraOne to see every EMA crossover signal across your watchlist — going back 52 weeks. The weekly EMA crossover is AltraOne's highest-conviction intermediate momentum signal; the Signal History page lets you track how these have played out over time.


Altra Score is a momentum indicator reflecting EMA alignment and RSI trend across daily, weekly, and monthly timeframes. It is not investment advice. Past momentum does not guarantee future performance. Please consult a SEBI-registered advisor before making investment decisions.

Related Insights

  • 3 NSE Financial Stocks See Bullish Momentum ShiftJul 15, 2026
  • NSE: Banking and Pharma Names Show Bullish TurnsJul 15, 2026
  • 3 NSE Stocks Catch Bullish Momentum Across 2 Key SectorsJul 10, 2026
  • Nifty Pharma Sees Bullish Momentum in Three StocksJul 10, 2026

More from AltraOne Insights

Brookfield Corp Signals Strong Bullish ShiftJul 16, 2026
Piramal Pharma's Altra Score Jumps to BullishJul 16, 2026
3 US Healthcare Stocks Show Bullish MomentumJul 16, 2026
3 US Industrials & Aerospace Stocks Turn BullishJul 16, 2026
Microsoft's Altra Score Jumps to Bullish: What Changed?Jul 16, 2026